Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes

NCT01324505 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: semaglutide
DRUG: placebo
DRUG: Microgyn®

Sponsor

Novo Nordisk A/S